Risk of Incident Psychosis and Mania With Prescription Amphetamines
American Journal of Psychiatry · 01.10.2024 · 181 (10) · 901-909
DOI: 10.1176/appi.ajp.20230329 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Psychiatry, erschienen am 01.10.2024. Verfasst von Lauren V Moran und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Psychotic Disorders, McLean Hospital, Belmont, MA (Moran, Shinn, Nielsen, Cohen, Erkol, Merchant, Mujica, Ongur); Division of Pharmacoepi…. Hauptthemen laut MEDLINE: Mania, Psychoses, Substance-Induced. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS.
Abstract (Originalsprache)
OBJECTIVE: Amphetamine prescribing has increased in the United States in recent years. Previous research identified an increased risk of incident psychosis with prescription amphetamines. The purpose of this study was to examine the impact of dose levels of prescription amphetamines on the risk of this rare but serious adverse outcome. METHODS: A case-control study using electronic health records was conducted to compare the odds of incident psychosis or mania with past-month exposure to prescription amphetamines. Case subjects were patients ages 16-35 hospitalized at McLean Hospital for incident psychosis or mania between 2005 and 2019. Control subjects were patients with an initial psychiatric hospitalization for other reasons, most commonly depression and/or anxiety. Amphetamine doses were converted to dextroamphetamine equivalents and divided into terciles. Secondary analyses evaluated the odds of psychosis or mania with methylphenidate use. RESULTS: Among 1,374 case subjects and 2,748 control subjects, the odds of psychosis and mania were increased for individuals with past-month prescription amphetamine use compared with no use (adjusted odds ratio=2.68, 95% CI=1.90-3.77). A dose-response relationship was observed; high doses of amphetamines (>30 mg dextroamphetamine equivalents) were associated with 5.28-fold increased odds of psychosis or mania. Past-month methylphenidate use was not associated with increased odds of psychosis or mania compared with no use (adjusted odds ratio=0.91, 95% CI=0.54-1.55). CONCLUSIONS: Although use of hospitalized control subjects excludes individuals with less severe disease, leading to selection bias, the study results suggest that caution should be exercised when prescribing high doses of amphetamines, with regular screening for symptoms of psychosis or mania.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Psychotic Disorders, McLean Hospital, Belmont, MA (Moran, Shinn, Nielsen, Cohen, Erkol, Merchant, Mujica, Ongur); Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and W…
Förderung
- NIMH NIH HHS
Zitieren
APA
Moran, L. V., Skinner, J. P., Shinn, A. K., Nielsen, K., Rao, V., Taylor, S. T., Cohen, T. R., Erkol, C., Merchant, J., Mujica, C. A., Perlis, R. H., & Ongur, D. (2024). Risk of Incident Psychosis and Mania With Prescription Amphetamines. American Journal of Psychiatry, 181(10), 901-909. https://doi.org/10.1176/appi.ajp.20230329
Vancouver
Moran LV, Skinner JP, Shinn AK, Nielsen K, Rao V, Taylor ST, et al. Risk of Incident Psychosis and Mania With Prescription Amphetamines. American Journal of Psychiatry. 2024;181(10):901-909. doi:10.1176/appi.ajp.20230329
BibTeX
@article{Moran2024,
author = {Moran, Lauren V and Skinner, Joseph P and Shinn, Ann K and Nielsen, Kathryn and Rao, Vinod and Taylor, S Trevor and Cohen, Talia R and Erkol, Cemre and Merchant, Jaisal and Mujica, Christin A and Perlis, Roy H and Ongur, Dost},
title = {Risk of Incident Psychosis and Mania With Prescription Amphetamines},
journal = {American Journal of Psychiatry},
year = {2024},
volume = {181},
number = {10},
pages = {901--909},
doi = {10.1176/appi.ajp.20230329}
}
EUVIMED